CEL-SCI CorpCVM
Market Cap: $66.4M
About: CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Employees: 44
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
2.58% less ownership
Funds ownership: 13.9% [Q1] → 11.32% (-2.58%) [Q2]
14% less funds holding
Funds holding: 77 [Q1] → 66 (-11) [Q2]
50% less capital invested
Capital invested by funds: $14.4M [Q1] → $7.11M (-$7.26M) [Q2]
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
89% less call options, than puts
Call options by funds: $19K | Put options by funds: $171K
Research analyst outlook
We haven’t received any recent analyst ratings for CVM.